A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

Saved in:
Bibliographic Details
Title: A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants
Authors: Bernstein, David I.1 david.bernstein@cchmc.org, Falloon, Judith2 falloonj@medimmune.com, Yi, Tingting2 yit@medimmune.com
Source: Vaccine. Sep2011, Vol. 29 Issue 40, p7042-7048. 7p.
Database: Environment Complete
Description
ISSN:0264410X
DOI:10.1016/j.vaccine.2011.07.031